Insmed
INSM
#1119
Rank
A$30.41 B
Marketcap
A$140.33
Share price
3.07%
Change (1 day)
-9.32%
Change (1 year)

Earnings for Insmed (INSM)

Earnings in 2025 (TTM): -A$1.83 Billion

According to Insmed's latest financial reports the company's current earnings are A$0.60 Billion. a decrease over its 2024 earnings that were of -A$1.19 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Insmed from 2000 to 2025

Annual earnings

Year Earnings Change
2025 -A$1.71 Billion43.91%
2024 -A$1.19 Billion23.71%
2023 -A$0.96 Billion45.77%
2022 -A$0.66 Billion15.83%
2021 -A$0.57 Billion50.19%
2020 -A$0.38 Billion16.4%
2019 -A$0.33 Billion-23.9%
2018 -A$0.43 Billion59.35%
2017 -A$0.27 Billion8.52%
2016 -A$0.25 Billion47.25%
2015 -A$0.17 Billion34.53%
2014 -A$0.13 Billion58.83%
2013 -A$78.23 Million35.14%
2012 -A$57.89 Million-31.92%
2011 -A$85.04 Million854.92%
2010 -A$8.91 Million-105.22%
2009 A$0.17 B-905.06%
2008 -A$21.18 Million-27.31%
2007 -A$29.14 Million-62.41%
2006 -A$77.51 Million98.19%
2005 -A$39.11 Million0.03%
2004 -A$39.1 Million159.07%
2003 -A$15.09 Million-69.31%
2002 -A$49.17 Million
2000 -A$44.33 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Novartis
NVS
A$22.49 B-1,421.75%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Gilead Sciences
GILD
A$13.96 B-920.40%๐Ÿ‡บ๐Ÿ‡ธ USA
Vertex Pharmaceuticals
VRTX
A$7.21 B-523.88%๐Ÿ‡บ๐Ÿ‡ธ USA
Sarepta Therapeutics
SRPT
-A$1.01 Billion-41.20%๐Ÿ‡บ๐Ÿ‡ธ USA
Aerie Pharmaceuticals
AERI
-A$33.13 Million-98.05%๐Ÿ‡บ๐Ÿ‡ธ USA
Array Technologies
ARRY
-A$2.69 Million-99.84%๐Ÿ‡บ๐Ÿ‡ธ USA